CDKN2A and glioblastoma: Given that EZH2 directly targeted Ink4a/Arf, a tumor suppressor locus that is frequently inactivated in human GBM (Brennan et al., 2013), it is possible that EZH2 in SVZ astrocytes increases their oncogenic potential.